Volume 85, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

Volume 79, Pages S3-S8 (April 2011)
Volume 70, Issue 1, Pages (July 2006)
Volume 90, Issue 1, Pages (July 2016)
Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).
Volume 67, Pages S1-S7 (June 2005)
Volume 73, Issue 11, Pages (June 2008)
Volume 73, Issue 1, Pages 3-5 (January 2008)
Volume 81, Issue 11, Pages (June 2012)
Volume 84, Issue 5, Pages (November 2013)
Fibroblast Growth Factor 23 and CKD Prognosis
Volume 87, Issue 4, Pages (April 2015)
Renal vitamin D receptor expression and vitamin D renoprotection
Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis
Phosphorus: Another Devil in Our Diet?
FGF23 or PTH: which comes first in CKD ?
Volume 90, Issue 1, Pages (July 2016)
Volume 68, Issue 4, Pages (October 2005)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 69, Issue 8, Pages (April 2006)
Volume 78, Issue 10, Pages (November 2010)
FGF23–parathyroid interaction: implications in chronic kidney disease
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Volume 83, Issue 5, Pages (May 2013)
Volume 81, Issue 6, Pages (March 2012)
Volume 88, Issue 3, Pages (September 2015)
Volume 92, Issue 1, Pages (July 2017)
Volume 79, Pages S3-S8 (April 2011)
Volume 80, Issue 5, Pages (September 2011)
Volume 60, Issue 4, Pages (October 2001)
VEGF receptor 2 blockade leads to renal cyst formation in mice
Volume 73, Issue 2, Pages (January 2008)
Volume 85, Issue 1, Pages (January 2014)
Volume 80, Issue 1, Pages (July 2011)
Volume 70, Issue 1, Pages (July 2006)
Volume 79, Pages S20-S23 (April 2011)
Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1α-hydroxylase  Mutsuko Ohnishi, Teruyo.
Use of vitamin D in chronic kidney disease patients
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Florian Lang, Michael Föller  Kidney International 
Plasma FGF23 levels increase rapidly after acute kidney injury
Volume 80, Issue 5, Pages (September 2011)
Volume 69, Issue 3, Pages (February 2006)
Volume 79, Issue 2, Pages (January 2011)
Volume 82, Issue 2, Pages (July 2012)
Volume 83, Issue 6, Pages (June 2013)
Volume 84, Issue 5, Pages (November 2013)
Volume 87, Issue 3, Pages (March 2015)
Volume 84, Issue 4, Pages (October 2013)
Harold M. Aukema, Ihsan Housini  Kidney International 
Volume 78, Issue 4, Pages (August 2010)
Fibroblast growth factor 23: the making of a hormone
Phosphate and the parathyroid
Latest findings in phosphate homeostasis
Volume 71, Issue 8, Pages (April 2007)
Volume 78, Issue 10, Pages (November 2010)
Volume 82, Issue 10, Pages (November 2012)
Volume 80, Issue 10, Pages (November 2011)
Increased parathyroid expression of klotho in uremic rats
Volume 75, Issue 3, Pages (February 2009)
Volume 72, Issue 11, Pages (December 2007)
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
The ins and outs of phosphate homeostasis
Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia  S. Faroqui, M. Levi,
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Marta Christov, Harald Jüppner  Kidney International 
Volume 83, Issue 1, Pages (January 2013)
Ronen Levi, Justin Silver  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
Regulation of serum calcium homeostasis.
Presentation transcript:

Volume 85, Issue 6, Pages 1340-1350 (June 2014) Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease  Daniela Spichtig, Hongbo Zhang, Nilufar Mohebbi, Ivana Pavik, Katja Petzold, Gerti Stange, Lanja Saleh, Ilka Edenhofer, Stephan Segerer, Jürg Biber, Philippe Jaeger, Andreas L. Serra, Carsten A. Wagner  Kidney International  Volume 85, Issue 6, Pages 1340-1350 (June 2014) DOI: 10.1038/ki.2013.526 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Fibroblast growth factor 23 (FGF23), parathyroid hormone (PTH), and renal function. Plasma concentrations of (a) FGF23, (b) PTH, (c) creatinine, and (d) urea after 2, 4, 6, and 8 weeks in cy/+ (black squares) and +/+ (wild type; white squares) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=11.5 and +/+=11. *P<0.05 and **P<0.001. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Fibroblast growth factor 23 (FGF23) expression in kidney. (a) Relative mRNA expression of FGF23 to 18S rRNA in bone and kidney after 2, 4, and 8 weeks in cy/+ (black bars) and +/+ (wild type; white bars) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=6 and +/+=5.5. **P<0.001. Immunohistochemistry for FGF23 (green), calbindin D28k (red), a marker for distal convoluted tubules and connecting tubules, and 4',6-diamidino-2-phenylindole (DAPI; blue, cell nuclei). (b, c) Kidneys from 8-week-old cy/+ rats, (d, e) kidneys from 8-week-old control rats, and (f) kidney from 8-week-old cy/+ rat incubated with secondary antibodies alone. Original magnification × 400. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Vitamin D3 metabolism. (a) Plasma concentration of 1,25-dihydroxyvitamin (1,25(OH)2) vitamin D3, and relative mRNA expression of the (b) vitamin D receptor (VDR) as well as (c) Cyp27b1 and (d) Cyp24a1 enzymes in the kidney to 18S rRNA after 2, 4, and 8 weeks in cy/+ (black bars) and +/+ (wild type; white bars) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=6 and +/+=5. *P<0.05 and **P<0.001. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Renal phosphate and calcium handling. Plasma concentrations of (a) phosphate and (b) calcium as well as (c) ratio of the maximum rate of tubular phosphate reabsorption to the glomerular filtration rate (TmP/GFR) and (d) fractional excretion of calcium (FECa) ratio after 2, 4, 6, and 8 weeks in cy/+ (black squares) and +/+ (wild type; white squares) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=11.5 and +/+ =11. *P<0.05. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 5 Phosphate transporter mRNA expression. Relative mRNA expression of (a) NaPi-IIa and (b) NaPi-IIc to 18S rRNA after 2, 4, and 8 weeks in cy/+ (black bars) and +/+ (wild type; white bars) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=6 and +/+=6. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 6 Phosphate transporter protein expression. Relative protein expression of NaPi-IIa and NaPi-IIc to β-actin after (a) 2, (b) 4, and (c) 8 weeks in cy/+ (black bars) and +/+ (wild type; white bars) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=6 and +/+=6. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 7 Phosphate and glucose uptake into renal brush border membrane vesicles. Phosphate uptake (a) without and (b) with phosphonoformic acid (PFA) and (c) glucose uptake after 2, 4, and 8 weeks in cy/+ (black bars) and +/+ (wild type; white bars) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=11 and +/+=7. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 8 Klotho expression and phosphorylation state of fibroblast growth factor (FGF) receptor substrate 2α (FRS2a). (a) Relative mRNA expression of Klotho in kidney to 18S rRNA after 2, 4, and 8 weeks; (b) relative protein expression of Klotho and (c) phosphorylation state of FRS2a (pFRS2a) to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) after 8 weeks in cy/+ (black bars) and +/+ (white bars) Han:SPRD rats (mean ±s.d.); number of animals (median): cy/+=4 and +/+=4. *P<0.05. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 9 Fibroblast growth factor 23 (FGF23), parathyroid hormone (PTH), ratio of the maximum rate of tubular phosphate reabsorption to the glomerular filtration rate (TmP/GFR), and renal function in Pkd1fl/fl mice. (a) Plasma intact FGF23 and (b) PTH as well as (c) TmP/GFR and (d) creatinine clearance after 10 weeks in Pkd1fl/fl, cre+ (black bars) and Pkd1fl/fl, cre- (white bars) mice (mean ±s.d.); number of animals (median): Pkd1fl/fl, cre+=7 and Pkd1fl/fl, cre-=16. *P<0.05. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 10 Fibroblast growth factor 23 (FGF23) and Klotho expression in bone and kidneys of Pkd1fl/fl mice. Relative mRNA expression of FGF23 in (a) kidney and (b) bone as well as (c) Klotho in kidney to 18S rRNA after 10 weeks in Pkd1fl/fl, cre+ (black bars) and Pkd1fl/fl, cre- (white bars) mice (mean ±s.d.); number of animals (median): Pkd1fl/fl, cre+=8 and Pkd1fl/fl, cre-=15. **P<0.001. Kidney International 2014 85, 1340-1350DOI: (10.1038/ki.2013.526) Copyright © 2014 International Society of Nephrology Terms and Conditions